As a patient, it’s so important to understand your condition. This is especially true for people with diabetes. Though diabetes has no known cure right now, you should be aware of the recent medical advances and discoveries as researchers work on finding a cure and improving treatments.
Having access to up-to-date news about diabetes research is one of the best ways to become an educated patient. That’s why we’ll update you with weekly research and treatment information, so that you can take the best care of your diabetes, whether it’s type 1, type 2, or gestational.
The goal is to make you an informed person who can talk with ease about diabetes, not just with relatives and friends but also with your doctor. The more you know, the more involved you can be in your healthcare decisions.
- The risk of autism may increase substantially for children born to mothers with diabetes who are also obese, says new research published in the journal Pediatrics.
- An artery-damaging compound linked with higher risk for atherosclerosis and heart attacks –trimethylamine N-oxide (TMAO)—also increases risk for heart failure, kidney failure and strokes, according to a string of recent research from the Cleveland Clinic.
- Medtronic, maker of insulin pumps and continuous glucose monitoring systems, has teamed up with IBM and its supercomputer, Watson, to develop an app usable on smart phones that can predict a potential problem hours before it's reality.
- After sleep deprivation, sleeping in can help normalize body's use of insulin, reduce diabetes risk, experts found.
- Gastric bypass surgery for obese individuals can greatly improve a patient’s quality of life and reduce type 2 diabetes symptoms, but the surgery also comes with risks of complications and symptoms.
- Abstaining from alcohol on a short-term basis improved insulin resistance, according to new research by scientists in the U.K.
- Metformin, a drug taken by many with diabetes, may have much greater potential beyond controlling blood sugar, some experts say.
- Weight loss surgery in patients age 60 and over is safe and effective, according to a new study published in the journal Obesity Surgery.
- Using a growth factor produced naturally by the human body – and used in spinal-fusion surgeries – scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have coaxed “leftover” cells from the pancreas to morph into insulin-producing islet cells.
- Viagra, a drug better known for its ability to improve men's erections, can also help improve insulin sensitivity in those who have prediabetes, potentially helping to delay or avoid the onset of type 2 diabetes, according to new research.
- Probiotics given to infants during the first month of life can reduce the risk of type 1 diabetes among those genetically predisposed to the condition, new research suggests.
- Women who increase their sleep by two hours or more a night over time face a 15% higher risk of developing type 2 diabetes than women who regularly sleep between 7 and 8 hours a night, concludes a recent study in Diabetologia, the journal of the European Association for the study of Diabetes.
- Patients newly diagnosed with type 2 diabetes may do better long term if they go on early, intensive insulin treatment instead of the standard route of using oral medication first, according to new research.
- Sipping a glass of red wine with dinner modestly boosted levels of “good” HDL cholesterol in a two-year study of 224 people with type 2 diabetes, led by researchers from Israel’s Ben-Gurion University of the Negev.
- Breakfast, often called the most important meal of the day, may be especially crucial if you have type 2 diabetes, suggests new research published in October in Diabetes Cares.
- Decades after her own pancreas stopped producing insulin, a Texas woman with tough-to-control type 1 diabetes no longer needs daily insulin shots thanks to a new transplant procedure developed at the Diabetes Research Institute (DRI) at UHealth — University of Miami Health System
- A new experimental endoscopic procedure significantly improved blood glucose levels in patients with type 2 diabetes. The results of the pilot study were presented at the 3rd World Congress on Interventional Therapies for Type 2 Diabetes.
- A pair of studies published last week in Diabetologia, the journal of the European Association for the Study of Diabetes, concluded that taking blood pressure medications at night reduced the risk of type 2 diabetes by 57%.
- Surprising results from a new study involving patients on insulin known as NPH (Humulin N, Novolin N) compared the effects of mixing or not mixing the insulin to the insulin concentrations in the blood following an injection.
- A recent University of Minnesota study has uncovered 49-65% higher odds for prediabetes in current marijuana smokers and former “heavy” users. The study was published in the September issue of the journal Diabetologia.
- New research presented last week at the annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm adds weight to the growing body of evidence linking endocrine-disrupting chemicals (EDCs) with diabetes.
- New research has found that following a diet that mimics fasting, but is less difficult, may slow aging and reduce the incidence of chronic diseases including diabetes.
- Smokers and anyone exposed regularly to second-hand smoke have a higher risk of developing type 2 diabetes than those who have never smoked, new research has confirmed.
- Exercising intensely for just a few minutes at a time may help those with diabetes reverse diabetes-related heart problems and also improve their blood sugar control, new research from Newcastle University in the U.K. suggests.
- A matchstick-sized pump that releases a constant trickle of the blood-sugar-lowering drug exenatide helped people with type 2 diabetes reduce their A1c levels further and lose more weight than those who took the blockbuster drug sitagliptin (Januvia) in a year-long study, according to a recent announcement from pump developer Intarcia Therapeutics, Inc.